The Hindu Business Line : CII biotech team to visit Canada, US

The main objective of the delegation's 10-day visit is to explore the possibilities of setting up partnership and joint ventures with international companies, especially those of the US and Canada and to learn about the latest developments in the international arena. The delegation is being led by the Chairman and Managing Director, Biocon India Ltd, Dr Kiran Mazumdar Shaw. The delegation will also take part in the Bio 2002 International Convention and Exhibition, scheduled to begin in Toronto on June 9.

Besides, the delegation will meet with the President of Bio, Mr Carl Feldbaum, and the Minister for Innovation and Science, Alberta, Mr Victor Doerksen.

During the six-day visit to the US, the team will have interaction with US biotech companies including Incyte Genomics, Affymax, Affymetrix and Genentech. A Biotech roundtable on `Building an Indo-US nexus' is also being organised.

Send this article to Friends by E-Mail

Stories in this Section
Kerala: Procedures on probes overhauled

Kerala: Special zones planned to lure investments

War fear has not hit foreign investors

AP: Ozone depleting substances registration made mandatory

Concessions to Pakistan -- India-EU trade talks likely next month

PSUs divested via strategic sales yielded better returns: FICCI

Bulk drugs SMEs in tech upgrade mode

TN Govt sets up 5-member panel for tax reforms

Safeguards for textiles against Chinese `threat'

Rana sees need for upgradation of powerlooms

`Textile exports not hit by tension on Indo-Pak border'